Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities

AKINCI, BARIŞ; Koseoglu, Fatos; Onay, Huseyin; Yavuz, Sevgi; ALTAY, CANAN; YILDIRIM ŞİMŞİR, ILGIN; Ozisik, Secil; Demir, Leyla; Korkut, Meltem; YILMAZ, NUSRET; ÖZEN, SAMİM; Akinci, Gulcin; ATİK, TAHİR; Calan, Mehmet; SEÇİL, MUSTAFA; ÇÖMLEKÇİ, ABDURRAHMAN; DEMİR, TEVFİK

doi:10.1016/j.metabol.2015.06.004

Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities

AKINCI B., Koseoglu F. D., Onay H., Yavuz S., ALTAY C., YILDIRIM ŞİMŞİR I., ...Daha Fazla

METABOLISM-CLINICAL AND EXPERIMENTAL, cilt.64, sa.9, ss.1086-1095, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 64 Sayı: 9
Basım Tarihi: 2015
Doi Numarası: 10.1016/j.metabol.2015.06.004
Dergi Adı: METABOLISM-CLINICAL AND EXPERIMENTAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1086-1095
Anahtar Kelimeler: APL, Diabetes, Hepatic steatosis, Hypertriglyceridemia, Insulin resistance
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective. Acquired partial lipodystrophy (APL) is a rare disorder characterized by progressive selective fat loss. In previous studies, metabolic abnormalities were reported to be relatively rare in APL, whilst they were quite common in other types of lipodystrophy syndromes.